Xylem Inc. SVP & CAO Receives RSU Grant of 4,225 Shares
Xylem Inc.
Subscribe to track XYL
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Insider Transaction Report: Xylem Inc. (NYSE: XYL)
**Reporting Owner:** McShane Geri-Michelle (SVP, CAO)
**Transaction Date:** October 1, 2026
**Transaction Type:** Grant / Award (Code A)
### Transaction Summary
- **Security:** Common Stock (Restricted Stock Units)
- **Shares Acquired:** 4,225
- **Price Per Share:** $0.00
- **Total Value:** $0.00
- **Post-Transaction Holdings:** 7,830 shares (Direct)
### Context & Significance
- **Significance:** Low
- **Details:** This filing reports a routine equity compensation award under the Xylem 2011 Omnibus Incentive Plan. The RSUs are scheduled to vest in 50% increments on October 1, 2028, and October 1, 2029.
Comprehensive Analysis
Overview
On October 1, 2026, Geri-Michelle McShane, Senior Vice President and Chief Accounting Officer of Xylem Inc. (NYSE: XYL), was granted 4,225 restricted stock units (RSUs) of Common Stock at $0.00 per share.
Transaction Breakdown
- Transaction Type: Grant / Award (Transaction Code A)
- Shares Granted: 4,225
- Transaction Price: $0.00
- Gross Value: $0.00
- Vesting Schedule: The RSUs were awarded pursuant to the Xylem 2011 Omnibus Incentive Plan and vest in one-half increments on October 1, 2028, and October 1, 2029.
- Direct Holdings Post-Transaction: 7,830 shares
Market & Strategic Context
This transaction represents standard equity-based executive compensation rather than open-market buying or selling activity. Because this acquisition reflects a scheduled retention and compensation grant rather than discretionary open-market sentiment, its trading significance is Low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.